The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Shire plc | SPONSORED ADR | 82481R106 | 4,220 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| Jazz Pharmaceuticals PLC | SHS USD | G50871105 | 2,791 | 16,200 | SH | SOLE | 16,200 | 0 | 0 | ||
| Merus N V | COM | N5749R100 | 1,692 | 75,060 | SH | SOLE | 75,060 | 0 | 0 | ||
| GW Pharmaceuticals Plc | ADS | 36197T103 | 1,339 | 9,600 | SH | SOLE | 9,600 | 0 | 0 | ||
| Abiomed Inc | COM | 003654100 | 5,400 | 13,200 | SH | SOLE | 13,200 | 0 | 0 | ||
| Adamas Pharmaceuticals Inc | COM | 00548A106 | 9,550 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
| Aerie Pharmaceuticals Inc | COM | 00771V108 | 998 | 14,779 | SH | SOLE | 14,779 | 0 | 0 | ||
| Agios Pharmaceuticals Inc | COM | 00847X104 | 3,074 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | ||
| Alexion Pharmaceuticals Inc | COM | 015351109 | 10,136 | 81,641 | SH | SOLE | 81,641 | 0 | 0 | ||
| Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 3,624 | 36,800 | SH | SOLE | 36,800 | 0 | 0 | ||
| Amicus Therapeutics Inc | COM | 03152W109 | 915 | 58,600 | SH | SOLE | 58,600 | 0 | 0 | ||
| Array Biopharma Inc | COM | 04269X105 | 11,647 | 694,500 | SH | SOLE | 694,500 | 0 | 0 | ||
| Biogen Inc | COM | 09062X103 | 10,510 | 36,208 | SH | SOLE | 36,208 | 0 | 0 | ||
| Biomarin Pharmaceutical Inc | COM | 09061G101 | 9,164 | 97,284 | SH | SOLE | 97,284 | 0 | 0 | ||
| Bluebird Bio Inc | COM | 09609G100 | 3,137 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| Celgene Corp | COM | 151020104 | 15,050 | 189,522 | SH | SOLE | 189,522 | 0 | 0 | ||
| Corvus Pharmaceuticals Inc | COM | 221015100 | 892 | 81,341 | SH | SOLE | 81,341 | 0 | 0 | ||
| Cymabay Therapeutics Inc | COM | 23257D103 | 1,945 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| Deciphera Pharmaceuticals Inc | COM | 24344T101 | 3,028 | 77,000 | SH | SOLE | 77,000 | 0 | 0 | ||
| Exelixis Inc | COM | 30161Q104 | 9,566 | 444,534 | SH | SOLE | 444,534 | 0 | 0 | ||
| FibroGen Inc | COM | 31572Q808 | 1,963 | 31,400 | SH | SOLE | 31,400 | 0 | 0 | ||
| G1 Therapeutics Inc | COM | 3621LQ109 | 3,121 | 72,000 | SH | SOLE | 72,000 | 0 | 0 | ||
| Gilead Sciences Inc | COM | 375558103 | 6,397 | 90,284 | SH | SOLE | 90,284 | 0 | 0 | ||
| Globus Med Inc | COM | 379577208 | 1,463 | 29,000 | SH | SOLE | 29,000 | 0 | 0 | ||
| Halozyme Therapeutics Inc | COM | 40637H109 | 7,227 | 428,633 | SH | SOLE | 428,633 | 0 | 0 | ||
| Horizon Pharma Plc | SHS | G4617B105 | 1,142 | 69,000 | SH | SOLE | 69,000 | 0 | 0 | ||
| Illumina Inc | COM | 452327109 | 12,568 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| Incyte Corp | COM | 45337C102 | 8,442 | 125,975 | SH | SOLE | 125,975 | 0 | 0 | ||
| Intersect Ent Inc | COM | 46071F103 | 4,189 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | ||
| Ionis Pharmaceuticals Inc | COM | 462222100 | 5,271 | 126,500 | SH | SOLE | 126,500 | 0 | 0 | ||
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 2,612 | 322,436 | SH | SOLE | 322,436 | 0 | 0 | ||
| Ligand Pharmaceuticals Inc | COM | 53220K504 | 7,250 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| Madrigal Pharmaceuticals Inc | COM | 558868105 | 2,790 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| Neurocrine Biosciences Inc | COM | 64125C109 | 16,061 | 163,500 | SH | SOLE | 163,500 | 0 | 0 | ||
| Paratek Pharmaceuticals Inc | COM | 699374302 | 1,051 | 103,500 | SH | SOLE | 103,500 | 0 | 0 | ||
| Portola Pharmaceuticals Inc | COM | 737010108 | 906 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
| Puma Biotechnology Inc | COM | 74587V107 | 2,732 | 46,300 | SH | SOLE | 46,300 | 0 | 0 | ||
| Radius Health Inc | COM | 750469207 | 554 | 18,799 | SH | SOLE | 18,799 | 0 | 0 | ||
| ReShape Lifesciences Inc | COM | 761123108 | 121 | 52,546 | SH | SOLE | 52,546 | 0 | 0 | ||
| Regeneron Pharmaceuticals | COM | 75886F107 | 10,808 | 31,330 | SH | SOLE | 31,330 | 0 | 0 | ||
| Rigel Pharmaceuticals Inc | COM NEW | 766559603 | 1,043 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
| Sage Therapeutics Inc | COM | 78667J108 | 6,726 | 42,996 | SH | SOLE | 42,996 | 0 | 0 | ||
| Sangamo Therapeutics Inc | COM | 800677106 | 1,605 | 113,000 | SH | SOLE | 113,000 | 0 | 0 | ||
| Sarepta Therapeutics Inc | COM | 803607100 | 3,568 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
| Seattle Genetics Inc | COM | 812578102 | 2,821 | 42,500 | SH | SOLE | 42,500 | 0 | 0 | ||
| Spark Therapeutics Inc | COM | 84652J103 | 992 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | 6,285 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Spring Bk Pharmaceuticals Inc | COM | 849431101 | 860 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 7,862 | 492,930 | SH | SOLE | 492,930 | 0 | 0 | ||
| Supernus Pharmaceuticals Inc | COM | 868459108 | 1,253 | 20,953 | SH | SOLE | 20,953 | 0 | 0 | ||
| Transenterix Inc | COM | 89366M201 | 3,823 | 889,082 | SH | SOLE | 889,082 | 0 | 0 | ||
| Verastem Inc | COM | 92337C104 | 3,435 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| Vertex Pharmaceuticals Inc | COM | 92532F100 | 14,144 | 83,222 | SH | SOLE | 83,222 | 0 | 0 | ||
| Viking Therapeutics Inc | COM | 92686J106 | 664 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||